Prenetics Global 与 NBA 达成多年合作,IM8 成为官方营养合作伙伴
6-K - Prenetics Global Ltd (0001876431) (Filer)
Prenetics Global 与 NBA 签署多年合作协议,IM8 成为 NBA 在澳大利亚和东南亚的官方营养合作伙伴。该合作于 2026 年 10 月 12 日宣布。此为公司发布的 6-K 报告内容。
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE
13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2026
Commission File Number 001-41401
Prenetics Global Limited
Unit 703-706, K11 Atelier 728 King’s Road, Quarry Bay Hong Kong | |||||
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXPLANATORY NOTE
On October 12, 2026, Prenetics Global Limited (the “Company”) issued a press release announcing a multi-year collaboration with the National Basketball Association (NBA) that makes IM8 the Official Nutrition Partner of the NBA in Australia and Southeast Asia. A copy of the press release is furnished as Exhibit 99.1 to this Report on Form 6-K (this "Report").
The information contained in this Report, including Exhibit 99.1 furnished herewith, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing or in this report.
INCORPORATION BY REFERENCE
This Report, along with Exhibit 99.1, is incorporated by reference into the registration statements on Form F-3 (File Nos. 333-265284, 333-276538 and 333-288824), and registration statements on Form S-8 (File Nos. 333-287017, 333-279019, 333-271552, 333-267956 and 333-298478) of Prenetics Global Limited (including any prospectuses forming a part of such registration statements), including all amendments thereto, filed with the U.S. Securities and Exchange Commission (the "SEC"), to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.
EXHIBIT INDEX
| Exhibit No. | Description | |||||||
| 99.1 | ||||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Prenetics Global Limited | ||||||||
| By: | /s/ Danny Sheng Wu Yeung | |||||||
| Name: | Danny Sheng Wu Yeung | |||||||
| Title: | Chief Executive Officer | |||||||
| Date: October 12, 2026 | ||||||||
来源:SEC EDGAR · 本站存档